{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T18:28:28Z","timestamp":1782584908090,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":316,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.neuropharm.2022.109127","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T11:08:28Z","timestamp":1652440108000},"page":"109127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations"],"prefix":"10.1016","volume":"214","author":[{"given":"Cynthia E.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley Maria","family":"Dourron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah W.","family":"Sweat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Garcia-Romeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"MacCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109127_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.pu.15.050194.002415","article-title":"Health status of vulnerable populations","volume":"15","author":"Aday","year":"1994","journal-title":"Annu. Rev. Publ. Health"},{"key":"10.1016\/j.neuropharm.2022.109127_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1353\/aiq.2000.0001","article-title":"Plastic shamans and Astroturf sun dances: new Age commercialization of Native American spirituality","volume":"24","author":"Aldred","year":"2000","journal-title":"Am. Indian Q."},{"key":"10.1016\/j.neuropharm.2022.109127_bib3","doi-asserted-by":"crossref","first-page":"100538","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.neuropharm.2022.109127_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11524-011-9614-1","article-title":"Health disparities and the criminal Justice System: an agenda for further research and action","volume":"89","author":"Binswanger","year":"2012","journal-title":"J. Urban Health"},{"key":"10.1016\/j.neuropharm.2022.109127_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMp2112233","article-title":"Combating structural inequities - diversity, equity, and inclusion in clinical and translational research","volume":"386","author":"Boulware","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109127_bib7","series-title":"Improving Cultural Competence to Reduce Health Disparities","author":"Butler","year":"2016"},{"key":"10.1016\/j.neuropharm.2022.109127_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1037\/a0025266","article-title":"Racial\/ethnic matching of clients and therapists in mental health services: a meta-analytic review of preferences, perceptions, and outcomes","volume":"58","author":"Cabral","year":"2011","journal-title":"J. Counsel. Psychol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib9","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109127_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/01419870802334531","article-title":"Race and ethnic differences in religious involvement: African Americans, Caribbean blacks and non-Hispanic whites","volume":"32","author":"Chatters","year":"2009","journal-title":"Ethn. Racial Stud."},{"key":"10.1016\/j.neuropharm.2022.109127_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J020v18n02_05","article-title":"Substance abuse counselors with and without a personal history of chemical dependency","volume":"18","author":"Culbreth","year":"2000","journal-title":"Alcohol Treat. Q."},{"key":"10.1016\/j.neuropharm.2022.109127_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1215\/00182168-2836928","article-title":"Salvador roquet, Mar\u00eda Sabina, and the trouble with jipis","volume":"95","author":"Dawson","year":"2015","journal-title":"Hisp. Am. Hist. Rev."},{"key":"10.1016\/j.neuropharm.2022.109127_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1353\/cpr.2019.0067","article-title":"Toward health equity: a national study of promising practices in community-based participatory research","volume":"13","author":"Duran","year":"2019","journal-title":"Prog. Comm. Health Partnerships: Res. Educat. Action"},{"key":"10.1016\/j.neuropharm.2022.109127_bib14","series-title":"Mar\u00eda Sabina: Her Life and Chants","author":"Estrada","year":"1981"},{"key":"10.1016\/j.neuropharm.2022.109127_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/02698811211069103","article-title":"Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 \u03bcg LSD in healthy participants within a novel intervention paradigm: a proof-of-concept study","volume":"36","author":"Family","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00006199-199803000-00005","article-title":"Conceptualizing vulnerable populations health-related research","volume":"47","author":"Flaskerud","year":"1998","journal-title":"Nurs. Res."},{"key":"10.1016\/j.neuropharm.2022.109127_bib17","doi-asserted-by":"crossref","first-page":"i6067","DOI":"10.1136\/bmj.i6067","article-title":"The war on drugs has failed: doctors should lead calls for drug policy reform","volume":"355","author":"Godlee","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2022.109127_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/09540261.2018.1474185","article-title":"Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy","volume":"30","author":"Hendricks","year":"2018","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109127_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0269881117735685","article-title":"The relationships of classic psychedelic use with criminal behavior in the United States adult population","volume":"32","author":"Hendricks","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib20","series-title":"Special Considerations for Evaluating Psilocybin-Facilitated Treatments in Vulnerable Populations. NIH Psilocybin Research Speaker Series","author":"Hendricks","year":"2021"},{"key":"10.1016\/j.neuropharm.2022.109127_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0140525X0999152X","article-title":"The weirdest people in the world?","volume":"33","author":"Henrich","year":"2010","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.neuropharm.2022.109127_bib22","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1080\/00036846.2016.1251562","article-title":"Religiosity and income: a panel cointegration and causality analysis","volume":"49","author":"Herzer","year":"2017","journal-title":"Appl. Econ."},{"key":"10.1016\/j.neuropharm.2022.109127_bib23","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1377\/hlthaff.2011.0613","article-title":"Eliminating health and health care disparities among the growing population of people with disabilities","volume":"30","author":"Iezzoni","year":"2011","journal-title":"Health Aff."},{"key":"10.1016\/j.neuropharm.2022.109127_bib24","first-page":"1","article-title":"Advancing the understanding of factors that influence client preferences for race and gender matching in psychotherapy","author":"Ilagan","year":"2021","journal-title":"Counsell. Psychol. Q."},{"key":"10.1016\/j.neuropharm.2022.109127_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2022.109127_bib27","doi-asserted-by":"crossref","first-page":"108715","DOI":"10.1016\/j.drugalcdep.2021.108715","article-title":"LSD use in the United States: trends, correlates, and a typology of use","volume":"223","author":"Killion","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2022.109127_bib28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.279.21.1703","article-title":"Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults","volume":"279","author":"Lantz","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109127_bib29","series-title":"Acid Dreams: the Complete Social History of LSD: the CIA, the Sixties, and beyond","author":"Lee","year":"1992"},{"key":"10.1016\/j.neuropharm.2022.109127_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/01640275211004152","article-title":"Culturally competent clinical care for older sexual minority adults: a scoping review of the literature","volume":"43","author":"MacCarthy","year":"2021","journal-title":"Res. Aging"},{"key":"10.1016\/j.neuropharm.2022.109127_bib31","series-title":"The Search for the Manchurian Candidate","author":"Marks","year":"1979"},{"key":"10.1016\/j.neuropharm.2022.109127_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000285648","article-title":"The treatment of twelve male homosexuals with 'L.S.D.' (followed by a detailed account of one of them who was a psychopathic personality)","volume":"10","author":"Martin","year":"1962","journal-title":"Acta Psychother. Psychosom."},{"key":"10.1016\/j.neuropharm.2022.109127_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1037\/0022-006X.68.3.438","article-title":"Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review","volume":"68","author":"Martin","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/a-1341-1907","article-title":"Classical psychedelics as therapeutics in psychiatry - current clinical evidence and potential therapeutic mechanisms in substance use and mood disorders","volume":"54","author":"Mertens","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2022.109127_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12888-018-1824-6","article-title":"Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature","volume":"18","author":"Michaels","year":"2018","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109127_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/0033354916667501","article-title":"Homelessness, unsheltered status, and risk factors for mortality: findings from the 100,000 Homes Campaign","volume":"131","author":"Montgomery","year":"2016","journal-title":"Publ. Health Rep."},{"key":"10.1016\/j.neuropharm.2022.109127_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/0145935X.2020.1818558","article-title":"The relationship between deficiency needs and growth needs: the continuing investigation of Maslow's theory","volume":"42","author":"Noltemeyer","year":"2021","journal-title":"Child. Youth Serv."},{"key":"10.1016\/j.neuropharm.2022.109127_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ptr\/8.4.455","article-title":"Therapist effects in three treatments for alcohol problems","volume":"8","year":"1998","journal-title":"Psychother. Res."},{"key":"10.1016\/j.neuropharm.2022.109127_bib39","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/QAD.0000000000002227","article-title":"Mental health and HIV\/AIDS: the need for an integrated response","volume":"33","author":"Remien","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.neuropharm.2022.109127_bib40","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00213-019-05279-z","article-title":"Replication and extension of a model predicting response to psilocybin","volume":"236","author":"Russ","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109127_bib41","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10488-016-0761-2","article-title":"Effect of patient-therapist gender match on psychotherapy retention among United States veterans with posttraumatic stress disorder","volume":"44","author":"Shiner","year":"2017","journal-title":"Adm. Pol. Ment. Health"},{"key":"10.1016\/j.neuropharm.2022.109127_bib42","doi-asserted-by":"crossref","first-page":"114327","DOI":"10.1016\/j.psychres.2021.114327","article-title":"Widening mental health and substance use inequities among sexual and gender minority populations: findings from a repeated cross-sectional monitoring survey during the COVID-19 pandemic in Canada","volume":"307","author":"Slemon","year":"2022","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109127_bib43","doi-asserted-by":"crossref","first-page":"774736","DOI":"10.3389\/fpsyt.2021.774736","article-title":"The need for psychedelic-assisted therapy in the Black community and the burdens of its provision","volume":"12","author":"Smith","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109127_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11606-010-1257-5","article-title":"Racial\/ethnic discrimination in health care: impact on perceived quality of care","volume":"25","author":"Sorkin","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.neuropharm.2022.109127_bib45","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jclp.22679","article-title":"Cultural adaptations and therapist multicultural competence: two meta-analytic reviews","volume":"74","author":"Soto","year":"2018","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/ajp.138.2.210","article-title":"The diagnostic status of homosexuality in DSM-III: a reformulation of the issues","volume":"138","author":"Spitzer","year":"1981","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109127_bib47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1360-0443.2001.967101511.x","article-title":"The effect of therapist\/patient race- and sex-matching in individual treatment","volume":"96","author":"Sterling","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2022.109127_bib48","series-title":"Storming Heaven: LSD and the American Dream","author":"Stevens","year":"1987"},{"key":"10.1016\/j.neuropharm.2022.109127_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1300\/J084v19n03_06","article-title":"Elderly prisoners: a growing and forgotten group within correctional systems vulnerable to elder abuse","volume":"19","author":"Stojkovic","year":"2007","journal-title":"J. Elder Abuse Negl."},{"key":"10.1016\/j.neuropharm.2022.109127_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1037\/a0023603","article-title":"Gay and bisexual male clients' perceptions of counseling: the role of perceived sexual orientation similarity and counselor universal-diverse orientation","volume":"58","author":"Stracuzzi","year":"2011","journal-title":"J. Counsel. Psychol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1037\/cou0000086","article-title":"A meta-analysis of multicultural competencies and psychotherapy process and outcome","volume":"62","author":"Tao","year":"2015","journal-title":"J. Counsel. Psychol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/07399330802523709","article-title":"Powerlessness, anger, and stress in African American women: implications for physical and emotional health","volume":"30","author":"Thomas","year":"2009","journal-title":"Health Care Women Int."},{"key":"10.1016\/j.neuropharm.2022.109127_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09687637.2021.1897331","article-title":"Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment","volume":"28","author":"Thrul","year":"2021","journal-title":"Drugs Educ. Prev. Pol."},{"key":"10.1016\/j.neuropharm.2022.109127_bib54","volume":"vol. 42","author":"Wasson","year":"1957"},{"key":"10.1016\/j.neuropharm.2022.109127_bib55","series-title":"Drugs: the Sacred Mushroom","author":"Wasson","year":"1970"},{"key":"10.1016\/j.neuropharm.2022.109127_bib56","series-title":"Mushrooms and Russian History","author":"Wasson","year":"1957"},{"key":"10.1016\/j.neuropharm.2022.109127_bib57","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2020.8598","article-title":"COVID-19 and racial\/ethnic disparities","volume":"323","author":"Webb Hooper","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109127_bib58","doi-asserted-by":"crossref","first-page":"108071","DOI":"10.1016\/j.drugalcdep.2020.108071","article-title":"Trends in LSD use among US adults: 2015-2018","volume":"212","author":"Yockey","year":"2020","journal-title":"Drug Alcohol Depend."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:17:16Z","timestamp":1758439036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822001861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"alternative-id":["S0028390822001861"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109127","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109127"}}